Luminal Breast Cancer, Surgical Decisions, and the Immunotherapy Question – Not all pCRs are Created Equal

This ESSO webinar examines how pCR should be interpreted in luminal breast cancer, where response may not carry the same prognostic and surgical meaning seen in other subtypes. It connects prognosis, pathology, operative decision-making, immunotherapy and de-escalation discussion into one practical clinical narrative. It is suited to surgeons and multidisciplinary professionals involved in breast cancer care.